Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Non-Surgical, Next Generation Cryoablation Technology- A Boon for Cancer Patients
    Health

    Non-Surgical, Next Generation Cryoablation Technology- A Boon for Cancer Patients

    By June 10, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], June 9: Cancer patients in India can now heave a sigh of relief, thanks to the availability of cryoablation technology in the country. Cryoablation is a minimally invasive image-guided (ultrasound or CT scan) treatment that uses extreme cold to freeze and accurately destroy diseased tissue within the tumour zone.  This technology is the brainchild of an Israeli company, IceCure Medical. Its flagship product, Pro-Sense, freezes tumours quickly and with minimal pain. It uses liquid nitrogen (LN2) for maximum freezing, safety, and efficacy. NovoMed Incorporation Pvt  Ltd is the authorized distributor of  IceCure Medical in India.

    During cryoablation, a thin, needle-like probe called a cryoprobe is inserted into the target area. The cryoprobe uses liquid nitrogen as a coolant, which rapidly cools the surrounding tissue. As the tissue freezes, ice crystals form, causing cellular damage and destruction. Extreme cold temperatures essentially freeze and kill abnormal cells.

    Cryoablation has several advantages over other treatment methods. It is considered a minimally invasive procedure, meaning it requires only a small incision or needle puncture, resulting in less trauma to the body and faster recovery times compared to open surgery. It can be performed under local anaesthesia, eliminating the need for general anaesthesia in many cases. Additionally, cryoablation is relatively precise, allowing for targeted treatment of the abnormal tissue while preserving surrounding healthy tissue. A hospital stay is not required in most cases.

    The specific application of cryoablation depends on the condition being treated. It is commonly used in the treatment of benign and malignant tumours of various kinds, including breast cancer, kidney cancer, liver cancer, lung cancer, bone, soft tissue, and other types of tumours.

    Dr.Bhavin Jankharia, Consultant Radiologist, observed,” My experience of using the IceCure machine has been excellent. Not only are the results good, but we also have great support from Jay and Prashant and their team, which makes our life and the patient’s life much easier when the cryoablation is being done. We also have terrific support from the Israeli team, specially Snir and Tlalit.  Cryoablation fills a niche in the overall ablation space. While RF (Radio Frequency) ablation has been around in clinical practice for more than 20 years now in India and microwave has slowly established itself in the last 5 years, cryoablation has been a slow mover. It is probably the best technique for fibromatosis and specific bone and soft tissue tumours and for renal tumours. In the lung and liver, it has to compete with RFA and microwave, both of which are equally good.”

    Dr Vimal Someshwar, Interventional Radiologist at Kokilaben Dhirubai Ambani Hospital and Medical Research Institute, opined,” In my personal experience, the results have been very good, and cryoablation is also excellent for pain management. This technology has tremendous potential and may have far wider applications in the future.”

    The cryoablation therapy was also recently introduced at the Kovai Medical Center in Coimbatore. Jay Mehta, Director–Sales, NovoMed Incorporation Pvt Ltd, stated, “We are indeed very happy to facilitate the availability of this futuristic and revolutionary technology in India.  The Indian populace should take maximum advantage of the same and freeze cancer in its tracks.”

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    How India’s Pet Industry Can Be Enhanced with Digital Infrastructure for Information, Intelligence and Trade

    October 29, 2026

    Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging

    October 28, 2026

    Child Not Improving in Therapy? Why a Full Child Psychological Assessment Should Come First, as Indian-Origin Parents Abroad Seek Online Help

    October 27, 2026

    Comments are closed.

    Recent Post
    • Bollywood Actor Kamlesh Sawant Takes On India’s English-Speaking Challenge in New MySivi Ad
    • World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK
    • Maxwell Engineering Solutions Limited’s IPO Opens on October 30, 2026
    • Hettich Launches Its Second Exclusive (HeX) Store in Bengaluru, strengthening its experimental footprint
    • IPO Opening Announcement of Vectras Enprocon Limited on BSE SME Platform
    • How India’s Pet Industry Can Be Enhanced with Digital Infrastructure for Information, Intelligence and Trade
    • Why Back and Neck Pain Is Becoming a Growing Concern Among Young Adults
    • Mumbai Hosts SPARK, India’s AI Creativity Summit, Showcasing Live AI Filmmaking to 500+ Creative Leaders

    Type above and press Enter to search. Press Esc to cancel.